Plasmalyte A
Plasmalyte A is an intervention with 6 clinical trials. Historical success rate of 80.0%.
Success Metrics
Based on 4 completed trials
Phase Distribution
Phase Distribution
2
Early Stage
1
Mid Stage
2
Late Stage
Highest Phase Reached
Phase 3Trial Status & Enrollment
80.0%
4 of 5 finished
20.0%
1 ended early
0
trials recruiting
6
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
A Study Evaluating the Efficacy and Safety of IV L-Citrulline for the Prevention of Clinical Sequelae of Acute Lung Injury Induced by Cardiopulmonary Bypass in Pediatric Patients Undergoing Surgery for Congenital Heart Defects
Human Mesenchymal Stromal Cells For Acute Respiratory Distress Syndrome (START)
Normal Saline Versus Plasmalyte in Initial Resuscitation of Trauma Patients
Comparative Analysis Between Ringer's Lactate vs Plasma Lyte-A as Cardiopulmonary Bypass Prime
Mesenchymal Stem Cells in Critical Limb Ischemia
Clinical Trials (6)
A Study Evaluating the Efficacy and Safety of IV L-Citrulline for the Prevention of Clinical Sequelae of Acute Lung Injury Induced by Cardiopulmonary Bypass in Pediatric Patients Undergoing Surgery for Congenital Heart Defects
Human Mesenchymal Stromal Cells For Acute Respiratory Distress Syndrome (START)
Normal Saline Versus Plasmalyte in Initial Resuscitation of Trauma Patients
Comparative Analysis Between Ringer's Lactate vs Plasma Lyte-A as Cardiopulmonary Bypass Prime
Mesenchymal Stem Cells in Critical Limb Ischemia
Ex Vivo Cultured Bone Marrow Derived Allogenic MSCs in AMI
All 6 trials loaded
Drug Details
- Intervention Type
- OTHER
- Total Trials
- 6